美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HORIZON KINETICS MEDICAL ETF

34.99

+0.03280.09%

盤後：35.110.1145+0.33%16:10 EDT

成交量：428

成交額：1.51萬

市值：1,644.36萬

市盈率：- -

高：35.11

開：35.11

低：34.99

收：34.96

52周最高：37.90

52周最低：28.87

股本：46.99萬

流通股本：46.99萬

量比：0.32

換手率：0.09%

股息：0.41

股息率：1.17%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

美股盤前｜庫珀醫療績後跌超17%，美鷹服飾跌14%；白宮的銅關税計劃陷入停滯；美債30年期收益率創2007年來新高

老虎资讯综合

華東醫藥：創新藥HDM2005入選國家科技重大專項

2026年國家醫保目錄談判收官：「三除外」落地，醫保商保雙軌並行，雙目錄如何重構創新藥支付邏輯

华夏时报网

諾華製藥(NVS.US)大股東呼籲改組董事會，以改善公司治理。此前該公司股價因連續試驗受挫於本周創下紀錄跌幅。大股東Da

Artisan Partners：在藥物試驗接連受挫後諾華應在董事會層面進行改組

信立泰重啓H股IPO，創新藥收入站上半壁江山，仍存單品依賴隱憂

ETF日報(09.10)丨臨床風險事件擾動等多因素疊加，創新藥板塊回落銀行股温和普漲

透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理

東北證券：創新藥BD和商業化持續兑現 CXO超預期，傳統板塊築底拐點

創新藥概念股震盪調整，百普賽斯跌超10%，萬邦醫藥、百花醫藥、千金藥業、博濟醫藥、諾思格跌超5%。

中信證券：創新藥出海漸入佳境，板塊進入盈利拐點

英硅智能(03696)：公司管線中領先的人工智能驅動候選創新藥物 Rentosertib已在針對特發性肺纖維化的III期臨床試驗中完成首例患者入組

滙豐：將諾華製藥的評級上調至「持有」，目標價110瑞士法郎。

艾伯維高管：穩健資產負債表與長期成長空間並存，公司可兼顧早期及晚期業務拓展機會——電話會議實錄

心血管新藥研發遇困局：諾華重磅臨床折戟 Lp（a）指標降了但心血管疾病風險沒降

每日经济新闻

對話復宏漢霖朱儁：體系出海要拿「長線收益」，2030年創新藥收入將反超生物類似藥

對話復宏漢霖朱儁：體系出海要拿「長線收益」，2030年創新藥收入將反超生物類似藥

賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告

【券商聚焦】中郵證券維持翰森製藥（03692）買入評級指創新藥成增長核心

2026國談第五日：商保創新藥目錄價格協商開始多家藥企攜核藥、CAR-T新藥等重磅藥物進場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MEDX/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9905,"timestamp":1789588800000,"preClose":34.9577,"halted":0,"volume":428,"hourTrading":{"tag":"盘后","latestPrice":35.105,"preClose":34.9905,"latestTime":"16:10 EDT","volume":6,"amount":209.943,"timestamp":1789589404310,"change":0.1145,"changeRate":0.003272,"amplitude":0},"delay":0,"changeRate":0.0009382768317136027,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"未開盤","change":0.0328,"latestTime":"09-16 16:00:00 EDT","open":35.105,"high":35.105,"low":34.9905,"amount":15054,"amplitude":0.003275,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9577,"sharesOutstanding":569946,"nav":34.96,"aum":16429312.16,"dividendRate":0.011689,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.105,"preClose":34.9905,"latestTime":"16:10 EDT","volume":6,"amount":209.943,"timestamp":1789589404310,"change":0.1145,"changeRate":0.003272,"amplitude":0},"volumeRatio":0.317037},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.317037,"shares":469946,"dividePrice":0.409,"high":35.105,"amplitude":0.003275,"preClose":34.9577,"low":34.9905,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9905,"eps":0,"divideRate":0.011689,"volume":428,"delay":0,"ttmEps":0,"open":35.105,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.2396,"twentyDayClose":36.4884,"sixtyDayClose":34.3915},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1140105110","title":"美股盤前｜庫珀醫療績後跌超17%，美鷹服飾跌14%；白宮的銅關税計劃陷入停滯；美債30年期收益率創2007年來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1140105110","media":"老虎资讯综合","labels":["AIColumn"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140105110?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 20:00","pubTimestamp":1789041651,"startTime":"0","endTime":"0","summary":"01 股市截至9月10日，美股三大期指涨跌互现。其仍保留2027年Palantir与纳指100 ETF长周期看跌合约，并进一步压缩其他头寸以降低风险暴露。该系列产品计划追踪热门美股及ETF的小时级收益倍数，为短线交易者提供新的杠杆工具。野村指出地缘政治、利率与通胀形成“负面风险三角”，推动看涨偏斜升至历史高位，市场或迎来更高波动。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"AIColumn","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","LU2041044095.USD","LU0006306889.USD","LU0056508442.USD","LU0541501648.USD","BK4141","LU1280957306.USD","LU0757428866.USD","LU1069347547.HKD","LU2505996509.AUD","LU1202635105.USD","IE0004086264.USD","LU1804176565.USD","AIFD","IE00BJLML261.HKD","LU0070217475.USD","LU0820562030.AUD","CGDG","LU0128525929.USD","SG9999017495.SGD","LU0359202008.SGD","LU0889566641.SGD","BK4553","LU1951200564.SGD","LU2413666426.HKD","LU0124676726.USD","LU2462591350.SGD","AGOX","LU0278409577.USD","BK7016","LU1400636491.USD","HK0000914660.USD","LU2125154935.USD","LU1366334651.USD","BK4548","LU2087621335.USD","METV","IE00B4YYXB79.USD","LU0061474960.USD","LU2347655073.USD","IE00BHPRN162.USD","LU2083900584.USD","LU1261432733.SGD","LU1718418525.SGD","LU0323239441.USD","BK4500","LU2023250330.USD","LU2092627202.USD","BK4535","LU0106261372.USD","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","IE0009G5SDU7.USD","LU0868494617.USD","IE00B19Z3581.USD","BK4526","LU2089283258.USD","LU1914381329.SGD","LU2543165471.USD","IE00BQXX3C00.GBP","LU0256863902.USD","TTEQ","FDTX","LU2458330243.SGD","BK4103","LU2360108059.USD","LU0868494708.USD","LU1116320737.USD","BK4566","LU2168564222.USD","HK0000914686.HKD","LU2023250504.SGD","LU0788109048.HKD","IE00B7KXQ091.USD","AIQ","LU0950373646.USD","LU0878005551.USD","SG9999015986.USD","LU1803068979.SGD","NBDS","SG9999014575.USD","LU1366334578.USD","DDM","LU0823434583.USD","LU1064131342.USD","LU0029864427.USD","IE00BDCRKT87.USD","LU0786609619.USD","LU2491050154.USD","LU1366192091.USD","LU1066051811.HKD","LU0133085943.USD","LU0300736062.USD","LU1989772923.USD","LU1778281490.HKD","FTXL","IE00BK4W5L77.USD","LU1983260115.SGD","LU1066053197.SGD","IE000KEQY171.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU1282649067.USD","LU0308772762.SGD","LU2065170008.USD","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","WLDR","IE000W1ABFV2.USD","LU2430703251.USD","LU0654597011.USD","TRFK","LEGR","LU2264538146.SGD","BOBP","LU0081259029.USD","LU0545039389.USD","SG9999004303.SGD","BK4503","LU1868838027.USD","LU2191332357.HKD","LU1868837136.USD","COPP","LU1992135472.HKD","LU1935042488.USD","LU1878469433.USD","PPH","LU0572939691.SGD","BK4116","LU0345770993.USD","LU1282649810.SGD","LU0174119429.USD","SPTE","LU1023057109.AUD","LU2211814178.USD","LU2237443549.SGD","LU0211327993.USD","09388","LU0965509101.SGD","ESUM","LU1400636657.SGD","LU0061474705.USD","LU0476273544.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","PICK","IE00BQXX3F31.USD","LU1974910355.USD","BK4007","LU2417539215.USD","LU2063271972.USD","LU0791590937.USD","AVEM","LU0238689110.USD","LU1023059493.AUD","LU2125909759.SGD","BK4097","EFIV","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU2463028550.USD","LU2896262040.SGD","BK4209","LU0256863811.USD","LU0143863784.USD","LU0572108347.SGD","LU2244417387.USD","XLK","SG9999000418.SGD","LU2487616109.SGD","LFGY","LU0070302665.USD","LU1935043536.SGD","LU0345768740.USD","LU0957791311.USD","LU0251132253.USD","IE000Q6AESB8.SGD","LU0345769631.USD","LU0444973449.USD","LU1989764748.USD","LU0096362180.USD","LU2125909916.SGD","LU0466842654.USD","LU0345768153.USD","LU0094547139.USD","BK4534","LU2065171402.SGD","USD","BLOX","LU2552382132.HKD",".DJI","LU1917777945.USD","ASIA","LU0289961442.SGD","EMET","LU2505996681.GBP","LU1791710582.SGD","LU0210528500.USD","IE00BN29S564.USD","LU2473716301.USD","LU1861215975.USD","IE00B19Z8W00.USD","IE00B19Z9505.USD","LU1069344957.HKD","LU1435385759.SGD","LU2271345857.HKD","LU1861127337.USD","DRMY","IE00B3SWFQ91.USD","LU1923622291.USD","LU0738911758.USD","LU0823397103.USD","HK0000306685.HKD","LU0057025933.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","HK0000819398.USD","SG9999014880.SGD","LU0553294199.USD","BK4532","LU1815336760.USD","LU0823413660.USD","LU2471134879.HKD","LU2361044865.SGD","LU0354030438.USD","SG9999015952.SGD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","SG9999014914.USD","SETM","LU0788109121.HKD","IE00B19Z8X17.USD","BK4023","LU0274383776.USD","09788","IE00B775H168.HKD","LU0072462426.USD","LU2213496289.HKD","DGT","IE0004445015.USD","LU2360106780.USD","IE00BZ1G4Q59.USD","IE00B5949003.HKD","LU2048586759.USD","LU0143863198.USD","IE00BFXG0V08.USD","IE00B19Z9Z06.USD","LU2100268510.USD","LU0097036916.USD","THMR","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","LU2491049909.HKD","VGT","CGNG","HK0000532082.HKD","BK4188","LU0208291251.USD","LU0820561909.HKD","LU1400636574.HKD","LU0266512127.USD","SHOC","FXL","BK4504","IE00BJJMRX11.SGD","LU2361045086.USD","LU0157215616.USD","LU1935043023.USD","LU1861558580.USD","AIPI","LU0942090050.USD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","LU0390134368.USD","LU1035775433.USD","LU0823431647.USD","IE0034235188.USD","BK4587","LU2360107168.USD","LU2381873111.SGD","LU0354030511.USD","LU2394011477.USD","LU1935042215.USD","IXN","IE00BMPRXQ63.HKD","LU2237443622.USD","LU0708995401.HKD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","DISK","LU0109391861.USD","SG9999015978.USD","BK4220","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","IE00BJTD4N35.SGD","LU2125909593.SGD","HK0000320223.HKD","SMH","SMHX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","ESLG","LU2430703178.SGD","LU2236285917.USD","DINT","LU0211328371.USD","LU2592432038.USD","LU1923623000.USD","LU1674673428.USD","LU2065169927.USD","LU2663582299.SGD","SPWO","LU0541502299.USD","LU1815336091.USD","USXF","IE00B894F039.SGD","LU0310800379.SGD","LU1674673691.USD","LU2111349929.HKD","LU2168564495.EUR","LU2148611432.USD","LU2433249047.HKD","LU0210533765.USD","IE0034235295.USD","LU0342679015.USD","IE00BD6J9T35.USD","LU2471134796.USD","IE00BZ199S13.USD","LU0265550359.USD","LU2357305700.SGD","LU0138981039.USD","NULC","AVXC","IE00B7SZLL34.SGD","COPX","LU2403377893.USD","LU1232071149.USD","RULE","LU1242518857.USD","LU2750360641.GBP","JGRO","COPA","BREW","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","TYLG","LU0330918003.SGD","IE00BJT1NW94.SGD","LU0566484027.USD","LU1571399168.USD","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU2326559502.SGD","LU0347712357.USD","LU0276348264.USD","LU1814569148.SGD","TEK","LU1244550221.USD","LU0726765562.USD","SG9999014898.SGD","LU2361044949.HKD","LU2168564149.EUR","LU0320765059.SGD","BK4609","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","LU0724617625.USD","IE00B1XK9C88.USD","IE0002270589.USD","IE0003U64NQ7.SGD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1880398554.USD","SG9999004220.SGD","SG9999002224.SGD","BK4598","GMET","LU1720051017.SGD","LU1066051498.USD","ILDR","HK0000320264.USD","IE00B3T34201.USD","LU0612318385.USD","LU0132412106.USD","LU0300736492.USD","LU2097344357.USD","SG9999014906.USD","LU1670756490.USD","LU2250418816.HKD","IE00B775SV38.USD","FMTL","LU2028103732.USD","LU2097344431.USD","LU1429558221.USD","LU0175139822.USD","LU1951198990.SGD","BK4551","LU0823421416.USD","LU1821325948.USD","LU2168563687.JPY","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","BK7094","LU2272731782.SGD","LU0640476718.USD","LU2087625088.SGD","LU1868836591.USD","IETC","SGXZ81514606.USD","LU0289960550.SGD","WISE","ARTY","BK7095","LU1496350171.SGD","BK4533","LU1244550494.USD","LU2168564065.EUR","LU2237438978.USD","IE00BDRTCR15.USD","LU0154236417.USD","LU0878004406.USD","LU1633808545.USD","LU1868837300.USD","LU0289739343.SGD","LU2054465674.USD","LU2237443382.USD","LU2242650005.HKD","SG9999018865.SGD","IE0009356076.USD","DOG","LU0788109477.HKD","LU2746668461.USD","PSI","BK4077","AIS","LU1979441026.SGD","LU2047632596.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU2602419157.SGD","BK4529","LU0882574139.USD","LU0395794307.EUR","FTEC","IE00BFSS8Q28.SGD","SGXZ23171101.USD","LU1989764664.SGD","LU2077746001.SGD","ROM","HK0000304797.USD","EDZ","LU0267386448.USD","LU0708994859.HKD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU2471134523.USD","IE000YTNTUN2.SGD","BK4567","LU0943347566.SGD","BK4198","IE00B1BXHZ80.USD","LU2413666699.HKD","IE0004445239.USD","LU0384037296.USD","BK4124","159571","LU0683600562.USD","LU2290526834.HKD","LU1316542783.SGD","LU1548497426.USD","IE00BFSS7M15.SGD","EART","BK4505","ACWX","LU1145028129.USD","EGGY","TINS","ABFL","BK4614","DIA","WUGI","LU0689472784.USD","LU0488056044.USD","MEMX","LU1721428933.USD","LU0234572021.USD","HK0000306701.USD","LU1720051108.HKD","LU0127658192.USD","LU0215105999.USD","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LU1861559042.SGD","LU1267930730.SGD","AVSE","BK4605","LU0965509283.SGD","IE00BJTD4V19.USD","LU0320765489.SGD","LU1066051225.USD","LU2237443465.HKD","IE0004091025.USD","BK4591","FAI","LU0612318971.USD","LU1144417596.USD","LU2237443895.HKD","LU2456880835.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU1244550577.SGD","IE0005OL40V9.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","LU2552382058.USD","BK4608","SOXY","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","LU2125909247.SGD","LU0823413587.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","LU0557290698.USD","LU1923622614.USD","LU2322448957.HKD","BK4543","LU0080751232.USD","LU0353189763.USD","LU0820561818.USD","IE00B19Z9P08.USD","LU1868837722.USD","LU2462157665.USD","LU2462591277.SGD","SG9999015945.SGD","LU0359201885.HKD","LU1691799644.USD","GAMR","LU1084165304.USD","LU2452424414.USD","EMSF","LU1116320901.HKD","BK4527","LU1861220033.SGD","IE00B4JS1V06.HKD","SG9999015358.SGD","BK4588","LU0353189680.USD","LU0511384066.AUD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","SOXQ","LU2756315318.SGD","LU2237443978.SGD","LU0964807845.USD","LU0203201768.USD","LU0265550946.USD","LU0889565833.HKD","KOMP","LU0050427557.USD","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","IE000ITXATA3.USD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","LU0823397285.USD","LU0823411888.USD","IE00B3S45H60.SGD","LU2746668974.SGD","LU2092937148.SGD","LU2294711713.HKD","LU1048588211.SGD","SG9999001424.SGD","SDOW","LU2756315664.SGD","LU0053666078.USD","LU0107464264.USD","LU0898699433.AUD","LU3102509885.SGD","BK4602","LU1935043452.HKD","UDOW","LU0143551892.USD","CGIC","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU2279689827.SGD","LU2552382215.SGD","LU1551013342.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","IE00BK4W5M84.HKD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU0329931173.USD","BK4610","LU0531971165.HKD","LU2420271590.USD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","SGXZ80539844.SGD","SGXZ31699556.SGD","BK4592","LU2272731600.USD","XTN","LU1127390331.HKD","IE00BYXW3230.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU0791591158.USD","LU0203202063.USD","BK4015","LU1267930813.SGD","LU2237957902.USD","ICOP","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","LU2065171311.SGD","LU2637965513.SGD","SG9999018857.SGD","LU0323591593.USD","XNTK","LU0792757196.USD","LU2347655156.SGD","LU1551013425.SGD","LU1992135399.USD","LU2133065610.SGD","LU0494093205.USD","LU0329931090.USD","LU1430597077.USD","LU0061475181.USD","LU0505663152.USD","LU0203347892.USD","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","LU1868836914.USD","LU1267930490.SGD","PTF","LU0075056555.USD","LU0661504455.SGD","LU1119994496.HKD","BK4612","CMAG","LU1852331112.SGD","BAI","LU0823421333.USD","LU0079474960.USD","LU1623119135.USD","VT","GB00BDT5M118.USD","LU2461242641.AUD","LU0949170772.SGD","LU0048584097.USD","LU0266512473.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","CLSE","TTXU","UMMA","LU1956131251.USD","LU0823434740.USD","LU1645745479.HKD","LU1242518931.SGD","IE00B2B36J28.USD","LU0096364046.USD","LU2106854487.HKD","LU2249611893.SGD","SNPE","LU0823431563.USD","LU0158827948.USD","LU2458330169.SGD","LU1035773651.USD","LU1629891620.HKD","BK4549","IE00BSNM7G36.USD","PBJ","BK4579","LU0323240290.USD","LU2357125470.USD","LU1988902786.USD","LU0072463663.USD","LU2089985449.USD","IE0001KFT4U8.USD","LU1559883803.SGD","KNOW","LU0444971666.USD","BK4094","TRUM","LU0069063385.USD","LU2298321311.HKD","LU2750360997.AUD","LU2286300806.USD","IE00BZ9MQY76.HKD","CORO","BK4008","LU1496350502.SGD","LU1839511570.USD","LU0672654240.SGD","LU2237957811.SGD","LU0528227936.USD","LU0472753341.HKD","LU0266013472.USD","LU0985320562.USD","CWI","BK4585","LU0912757837.SGD","LU0979878070.USD","LU0310799852.SGD","LU0345780950.USD","IE00BJJMRY28.SGD","LU1267930573.SGD","LU1880398471.USD","IE00B5TLWC47.USD","LU1868836757.USD","LU0264606111.USD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666602598","title":"華東醫藥：創新藥HDM2005入選國家科技重大專項","url":"https://stock-news.laohu8.com/highlight/detail?id=2666602598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666602598?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:49","pubTimestamp":1789040985,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666560028","title":"2026年國家醫保目錄談判收官：「三除外」落地，醫保商保雙軌並行，雙目錄如何重構創新藥支付邏輯","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560028","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560028?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:12","pubTimestamp":1789038763,"startTime":"0","endTime":"0","summary":"9月9日正午，北京西黄城根北街2号全国人大会议中心。最后一家参与商保创新药目录价格协商的企业代表走出大门，历时五天的2026年国家医保目录现场谈判竞价与商保创新药目录价格协商正式收官。新版国家基本医保药品目录与商保创新药目录预计今年11月公布，2027年1月1日起统一执行。五天时间里，124个目录外药品先后完成基本医保谈判竞价，12个创新药冲击商保创新药目录价格协商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609103870706515.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609103870706515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LNGR","MEDX","159992","06978","IBBQ","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666622025","title":"諾華製藥(NVS.US)大股東呼籲改組董事會，以改善公司治理。此前該公司股價因連續試驗受挫於本周創下紀錄跌幅。大股東Da","url":"https://stock-news.laohu8.com/highlight/detail?id=2666622025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666622025?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:25","pubTimestamp":1789035953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVS","LU0320765489.SGD","SYLD","LU0208291251.USD","IE00B4R5TH58.HKD","BK4532","BK4578","BK4588","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","MEDX","PPH","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","LU0070302665.USD","LU0211331839.USD","WCEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562462","title":"Artisan Partners：在藥物試驗接連受挫後 諾華應在董事會層面進行改組","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666562462?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 18:23","pubTimestamp":1789035834,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0009355771.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","PPH","BK4578","LU0211331839.USD","LU0208291251.USD","MEDX","BK4007","LU0070302665.USD","IE00B4R5TH58.HKD","NVS","IE00BJT1NW94.SGD","BK4532","BK4585","BK4588","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666648561","title":"信立泰重啓H股IPO，創新藥收入站上半壁江山，仍存單品依賴隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2666648561","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666648561?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 17:29","pubTimestamp":1789032552,"startTime":"0","endTime":"0","summary":"业务层面，信立泰转型取得阶段性成果的同时，核心产品收入集中的风险始终悬而未决。作为转型最重要的产品，信立坦2024 年销售额约 15 亿元，是公司创新药板块最主要的收入来源，公司创新药板块收入高度依赖这一款降压药物。虽然后续信超妥、复立坦、复立安等多款创新产品陆续获批、纳入医保，形成产品梯队，但是这些新产品体量尚小，短期内难以替代信立坦的收入贡献，公司仍然处于单品依赖阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789029785904368871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","KCE","BK0187","FRHC","LNGR","IPOS","159992","002294","REDS","BK1161","BK4127","BK1574","06978","BK0196","BK0188","IBBQ","MEDX","BK0183","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666693435","title":"ETF日報(09.10)丨臨床風險事件擾動等多因素疊加，創新藥板塊回落 銀行股温和普漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2666693435","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666693435?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 16:43","pubTimestamp":1789029788,"startTime":"0","endTime":"0","summary":"临床风险事件扰动等多因素叠加，创新药板块集体回落；定增政策红利释放、中报验证盈利韧性，银行板块温和普涨。行业表现临床风险事件扰动、海外利率预期反复与资金风格轮动三重因素叠加，创新药板块集体回落。截至收盘，恒生创新药ETF华泰柏瑞跌2.93%，报1.356元；港股通创新药ETF工银跌2.67%，报1.132元；港股创新药ETF广发跌2.65%，报1.251元。截至收盘，银行AH优选ETF招商涨1.65%，报1.603元；银行ETF汇添富涨1.56%，报1.5元；银行ETF华夏涨1.39%，报1.829元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ABEQ","ROPE","VALQ","BK1161","IBBQ","PRF","EQRR","MEDX","DFLV","TALV","VLUE","BKDV","PY","SPVM","VTV","BK4588","CGVV","BK4550","BK4585","LNGR","FDN","BK1574","159992","VUSV","SWP","06978","VMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755282","title":"透景生命(300642.SZ)控股子公司申報醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755282","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755282?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 11:50","pubTimestamp":1789012238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司上海脉示生物技术有限公司申报的医疗器械注册申请于近日获得了上海市药品监督管理局的受理，产品名称：四项抗癫痫药物浓度测定试剂盒(液相色谱串联质谱法)。该产品用于检测人体血清样本中的丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦浓度。临床上用于丙戊酸、奥卡西平代谢物(10,11-二氢-10-羟基卡马西平)、托吡酯、左乙拉西坦血药浓度的监测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK0046","BK1583","MEDX","BK1100","BK0239","LNGR","AGNG","BK0042","HART","RSPH","PTH","300642","IEIH","BK1574","LGHT","MDEV","GDOC","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513175","title":"東北證券：創新藥BD和商業化持續兑現 CXO超預期，傳統板塊築底拐點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513175?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:55","pubTimestamp":1789005326,"startTime":"0","endTime":"0","summary":"东北证券主要观点如下：创新药板块：海外创新药产业高景气延续，国产药企有望承接红利Pharma依托多元路径实现营收稳健增长，Biotech凭借BD和商业化释放业绩弹性。多家创新药企业2026H1业绩超预期增长，这与CXO板块公司的半年度业绩相印证，进一步确认了板块的中期产业趋势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","IBBQ","000686","CXO","BK0183","WX","BK0028","BK1161","06978","MEDX","159992","BK1574","BK0276","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666746559","title":"創新藥概念股震盪調整，百普賽斯跌超10%，萬邦醫藥、百花醫藥、千金藥業、博濟醫藥、諾思格跌超5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666746559","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666746559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:49","pubTimestamp":1789004940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MEDX","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555207","title":"中信證券：創新藥出海漸入佳境，板塊進入盈利拐點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555207","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555207?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 08:24","pubTimestamp":1788999885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555270","title":"英硅智能(03696)：公司管線中領先的人工智能驅動候選創新藥物 Rentosertib已在針對特發性肺纖維化的III期臨床試驗中完成首例患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555270","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555270?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 08:20","pubTimestamp":1788999632,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 发布公告，公司管线中领先的AI驱动候选创新药物 Rentosertib，已于北京协和医院完成III期临床试验的首例患者入组及给药;同日，上海市肺科医院亦完成了其在该试验的首例患者入组。GENESIS-IPF-3为一项评估Rentosertib用于特发性肺纤维化患者的III期临床试验。本试验旨在评估Rentosertib是否能比IIa期研究提供涵盖更大患者群体、且更长时间治疗的临床意义上的获益。Rentosertib透过抑制TNIK，旨在阻断或逆转纤维化进程，为IPF患者提供具备疾病改善潜力的治疗方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["OGIG","PSQ","159992","MFIG","IBBQ","PSYK","NBDS","06978","TQQY","AIBU","NOCT","161631","QSWN","MVPS","GK","AGIX","CPNQ","AIQU","PBOT","CWC","KOMP","IBBJ","NEWZ","AQGX","TECY","CHAT","03696","ARTY","QQA","LNGR","GPIQ","BMED","VUSE","QMAR","TQQQ","QQQ","NJUL","QQQX","MDTX","TARK","DQJN","WPAI","MEDX","LCLG","QID","QTOC","AIFD","NJAN","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553725","title":"滙豐：將諾華製藥的評級上調至「持有」，目標價110瑞士法郎。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553725","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666553725?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 07:44","pubTimestamp":1788997467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4007","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4578","IE00B2B36J28.USD","IE0009355771.USD","BK4532","IE0002141913.USD","FXF","BK4588","NVS","LU0208291251.USD","LU0211331839.USD","PPH","MEDX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191303955","title":"艾伯維高管：穩健資產負債表與長期成長空間並存，公司可兼顧早期及晚期業務拓展機會——電話會議實錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1191303955","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191303955?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:56","pubTimestamp":1788965760,"startTime":"0","endTime":"0","summary":"在近日一场备受关注的电话会议中，艾伯维公司高管明确表示，凭借其稳健的资产负债表以及充裕的长期增长跑道，公司目前能够同时审视并把握早期与晚期阶段的业务拓展契机。这一表态暗示，这家制药巨头在战略布局上拥有充分的灵活性与多元选择空间，既可着眼于处于萌芽阶段的创新资产，亦不排除对相对成熟项目的果断介入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","LU1989772923.USD","LU2237443549.SGD","LU1929549753.HKD","BK4533","LU1057294990.SGD","LU1244550577.SGD","FHLC","IE00BLSP4452.SGD","LU0170899867.USD","LU1037948897.HKD","LU2133065610.SGD","XLV","IE000SO60NU8.SGD","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0545039389.USD","LU0661504455.SGD","PJP","LU0868494617.USD","LU2125909593.SGD","IE00BGHQF631.EUR","LU1934455863.HKD","LU1989771016.USD","LU0122379950.USD","SG9999003800.SGD","LU0211328371.USD","BK4581","LU0057025933.USD","LU1430594728.SGD","LU0158827948.USD","LU0708994859.HKD","LU0310800379.SGD","LU0124676726.USD","LU0820561909.HKD","LU0310799852.SGD","LU0912757837.SGD","LU2237443622.USD","LU0256863811.USD","LU2347655073.USD","IE00B3PB1722.GBP","IE0000B7K699.USD","LU1551013342.USD","LU0058720904.USD","IE0004445239.USD","LU1236620750.USD","LU2125909247.SGD","LU1670627923.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0289961442.SGD","LU0859254822.USD","LU2089984988.USD","MEDX","LU1037948541.HKD","IE00BVYPNV92.GBP","LU2129689431.USD","SG9999015986.USD","IE0009355771.USD","JDOC","LU0472753341.HKD","SG9999011175.SGD","LU2089284900.SGD","SG9999001440.SGD","LU1162221912.USD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU2237443978.SGD","IE00B42XCP33.USD","LU0417517546.SGD","LU0114720955.EUR","LU0965508806.USD","IE00BVYPNW00.USD","LU1291159041.SGD","LU0689472784.USD","LU1244550221.USD","LU2112291526.USD","LU1934455277.USD","IE00BLSP4239.USD","LU1839511570.USD","LU0553294199.USD","IE0002141913.USD","LU0985320562.USD","LU0320765646.SGD","BK4559","LU0456855351.SGD","IE00BDGV0183.EUR","LU0234570918.USD","LU0868494708.USD","LU0965509010.AUD","LU0689626769.HKD","LU0098860793.USD","LU0738911758.USD","SG9999015945.SGD","LU0795875086.SGD","SG9999015978.USD","LU0726765562.USD","LU1670628061.USD","IE0002270589.USD","IE00B2B36J28.USD","LU1923622614.USD","LU2468319806.SGD","LU0029864427.USD","IE000MB6IJN5.SGD","LU2237443895.HKD","BK4534","LU2347655156.SGD","LU1496350171.SGD","LU0203345920.USD","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU0211327993.USD","BK4139","LU0823416689.USD","LU1003077747.HKD","LU0882574055.USD","LU1267930490.SGD","IE000F7OJYX1.SGD","LU0861579265.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1983299246.USD","LU2129689514.USD","LU0432979614.USD","LU1093756325.SGD","LU1023059063.AUD","GLAM","LU0128525929.USD","LU1732800096.USD","LU1093756168.USD","AGNG","LU0069063385.USD","BK4550","VHT","LU2237443465.HKD","LU0965509283.SGD","LU1496350502.SGD","IE000WAW04H5.SGD","LU0942090050.USD","LU0256863902.USD","LU1934455194.USD","IE00B19Z3581.USD","IXJ","LU0820561818.USD","LU1074936037.SGD","RXL","LU0395794307.EUR","LU0965509101.SGD","IYH","BK4588","IE00BFTCPJ56.SGD","LU2357627491.SGD","LU0203347892.USD","LU0511384066.AUD","LU2023251221.USD","LU1061106388.HKD","FTXH","LU0234572021.USD","LU2089283258.USD","LU0289739699.SGD","LU2129689605.HKD","ABBV","LU0289739343.SGD","TRUH","LU2087621335.USD","LU1244550494.USD","LU1585245621.USD","LU1718418525.SGD","LU0949170772.SGD","LU1236620834.HKD","LU1551013425.SGD","PPH","LU0198837287.USD","LU0943347566.SGD","BK4566","LU1732799900.SGD","LU1989772840.SGD","LU2237443382.USD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666531862","title":"心血管新藥研發遇困局：諾華重磅臨床折戟 Lp（a）指標降了但心血管疾病風險沒降","url":"https://stock-news.laohu8.com/highlight/detail?id=2666531862","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666531862?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:52","pubTimestamp":1788965533,"startTime":"0","endTime":"0","summary":"9月4日，诺华与Ionis合作开发的Lp（a）〔即：脂蛋白（a）——编者注〕靶向药物pelacarsen的Lp（a）HORIZONⅢ期临床试验公布结果。这款被行业寄予厚望的候选药物，虽能大幅降低Lp（a）水平，却未能显著降低心血管事件风险，给全球心血管创新药赛道投下了一片不确定性阴影。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609093869631090.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609093869631090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE0009355771.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","NVS","BK4007","IE00B4R5TH58.HKD","BK4585","IE00BFTCPJ56.SGD","BK4588","IE0002141913.USD","LU0208291251.USD","BK4578","LU0211331839.USD","PPH","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4532","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666356195","title":"對話復宏漢霖朱儁：體系出海要拿「長線收益」，2030年創新藥收入將反超生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2666356195","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666356195?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 21:04","pubTimestamp":1788959040,"startTime":"0","endTime":"0","summary":"新浪科技讯 9月9日晚间消息，在2026亚布力论坛夏季年会期间，在与新浪科技的对话中，复宏汉霖执行董事、首席执行官朱俊博士系统阐释了公司“体系出海”战略的底层逻辑。另一种是复宏汉霖坚持的“体系出海”，最终目的是拿到“长线收益”。营收方面，朱俊表示公司上半年实现营收35.88亿元，其中海外收入占比达19%，海外产品销售收入同比大幅提升159.4%至1.05亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-09/doc-inirfumn8933987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02696","LU2272731865.HKD","LU2322448791.USD","BK1161","159992","BK1574","HK0000165453.HKD","LNGR","HK0000306701.USD","IBBQ","HK0000306685.HKD","LU1992135399.USD","LU1992135472.HKD","LU2272731600.USD","IBB","HK0000320223.HKD","LU2272731782.SGD","XPH","LU2473716301.USD","HK0000320264.USD","06978","IE00B5TLWC47.USD","BK4585","MEDX","LU2322448957.HKD","PPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533226","title":"對話復宏漢霖朱儁：體系出海要拿「長線收益」，2030年創新藥收入將反超生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533226","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533226?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 20:54","pubTimestamp":1788958467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2473716301.USD","LNGR","IBBQ","PPH","IBB","LU1992135472.HKD","LU2272731865.HKD","BK4585","LU1992135399.USD","LU2272731600.USD","XPH","BK4588","LU2272731782.SGD","LU2322448957.HKD","MEDX","LU2322448791.USD","IE00B5TLWC47.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582190","title":"賽諾醫療：關於參加上海證券交易所科創板2026年半年度醫療器械及醫療設備行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582190","media":"同花顺","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582190?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:39","pubTimestamp":1788950340,"startTime":"0","endTime":"0","summary":"    证券日报网讯9月9日，赛诺医疗发布公告称，公司计划于2026年9月17日15：00-17：00参加上海证券交易所组织的科创板2026年半年度医疗器械及医疗设备行业集体业绩说明 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260909/c679749361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0251","IEIH","BK1100","IHI","GDOC","BK4588","688108","RSPH","09996","BK1574","XHE","KSTR","MEDX","MDEV","LGHT","PTH","HART","BK4585","BK1583","LNGR","AGNG","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458356","title":"【券商聚焦】中郵證券維持翰森製藥（03692）買入評級 指創新藥成增長核心","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458356","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458356?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 15:32","pubTimestamp":1788939161,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中邮证券发布研报指，翰森制药 发布2026年中报，2026H1实现收入83.04亿元，同比增长11.7%；归母净利润42.58亿元，同比增长35.8%，利润高增部分得益于约6.31亿元的投资收益等一次性项目。创新药已成为公司增长的绝对核心。创新药收入达70.92亿元，同比增长15.4%，占总收入比重由去年同期的82.7%提升至85.4%。其中抗肿瘤领域收入54.73亿元，占总收入65.9%；非肿瘤领域收入28.31亿元，占总收入34.1%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjdhYmE3ZDczMTc4NjgyMDYzMDA3NjI=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991138","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","LNGR","MEDX","06978","KCE","159992","161027","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666305240","title":"2026國談第五日：商保創新藥目錄價格協商開始 多家藥企攜核藥、CAR-T新藥等重磅藥物進場","url":"https://stock-news.laohu8.com/highlight/detail?id=2666305240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666305240?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 09:06","pubTimestamp":1788915970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159992","06978","BK1161","MEDX","BK1574","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":8,"totalSize":261,"code":"91000000","status":"200"}]}}